No Arabic abstract
Both Bayesian and varying coefficient models are very useful tools in practice as they can be used to model parameter heterogeneity in a generalizable way. Motivated by the need of enhancing Marketing Mix Modeling at Uber, we propose a Bayesian Time Varying Coefficient model, equipped with a hierarchical Bayesian structure. This model is different from other time varying coefficient models in the sense that the coefficients are weighted over a set of local latent variables following certain probabilistic distributions. Stochastic Variational Inference is used to approximate the posteriors of latent variables and dynamic coefficients. The proposed model also helps address many challenges faced by traditional MMM approaches. We used simulations as well as real world marketing datasets to demonstrate our model superior performance in terms of both accuracy and interpretability.
Marketing mix models (MMMs) are statistical models for measuring the effectiveness of various marketing activities such as promotion, media advertisement, etc. In this research, we propose a comprehensive marketing mix model that captures the hierarchical structure and the carryover, shape and scale effects of certain marketing activities, as well as sign restrictions on certain coefficients that are consistent with common business sense. In contrast to commonly adopted approaches in practice, which estimate parameters in a multi-stage process, the proposed approach estimates all the unknown parameters/coefficients simultaneously using a constrained maximum likelihood approach and solved with the Hamiltonian Monte Carlo algorithm. We present results on real datasets to illustrate the use of the proposed solution algorithm.
One of the most significant barriers to medication treatment is patients non-adherence to a prescribed medication regimen. The extent of the impact of poor adherence on resulting health measures is often unknown, and typical analyses ignore the time-varying nature of adherence. This paper develops a modeling framework for longitudinally recorded health measures modeled as a function of time-varying medication adherence or other time-varying covariates. Our framework, which relies on normal Bayesian dynamic linear models (DLMs), accounts for time-varying covariates such as adherence and non-dynamic covariates such as baseline health characteristics. Given the inefficiencies using standard inferential procedures for DLMs associated with infrequent and irregularly recorded response data, we develop an approach that relies on factoring the posterior density into a product of two terms; a marginal posterior density for the non-dynamic parameters, and a multivariate normal posterior density of the dynamic parameters conditional on the non-dynamic ones. This factorization leads to a two-stage process for inference in which the non-dynamic parameters can be inferred separately from the time-varying parameters. We demonstrate the application of this model to the time-varying effect of anti-hypertensive medication on blood pressure levels from a cohort of patients diagnosed with hypertension. Our model results are compared to ones in which adherence is incorporated through non-dynamic summaries.
We propose a general Bayesian approach to modeling epidemics such as COVID-19. The approach grew out of specific analyses conducted during the pandemic, in particular an analysis concerning the effects of non-pharmaceutical interventions (NPIs) in reducing COVID-19 transmission in 11 European countries. The model parameterizes the time varying reproduction number $R_t$ through a regression framework in which covariates can e.g be governmental interventions or changes in mobility patterns. This allows a joint fit across regions and partial pooling to share strength. This innovation was critical to our timely estimates of the impact of lockdown and other NPIs in the European epidemics, whose validity was borne out by the subsequent course of the epidemic. Our framework provides a fully generative model for latent infections and observations deriving from them, including deaths, cases, hospitalizations, ICU admissions and seroprevalence surveys. One issue surrounding our models use during the COVID-19 pandemic is the confounded nature of NPIs and mobility. We use our framework to explore this issue. We have open sourced an R package epidemia implementing our approach in Stan. Versions of the model are used by New York State, Tennessee and Scotland to estimate the current situation and make policy decisions.
Under-representation of certain populations, based on gender, race/ethnicity, and age, in data collection for predictive modeling may yield less-accurate predictions for the under-represented groups. Recently, this issue of fairness in predictions has attracted significant attention, as data-driven models are increasingly utilized to perform crucial decision-making tasks. Methods to achieve fairness in the machine learning literature typically build a single prediction model subject to some fairness criteria in a manner that encourages fair prediction performances for all groups. These approaches have two major limitations: i) fairness is often achieved by compromising accuracy for some groups; ii) the underlying relationship between dependent and independent variables may not be the same across groups. We propose a Joint Fairness Model (JFM) approach for binary outcomes that estimates group-specific classifiers using a joint modeling objective function that incorporates fairness criteria for prediction. We introduce an Accelerated Smoothing Proximal Gradient Algorithm to solve the convex objective function, and demonstrate the properties of the proposed JFM estimates. Next, we presented the key asymptotic properties for the JFM parameter estimates. We examined the efficacy of the JFM approach in achieving prediction performances and parities, in comparison with the Single Fairness Model, group-separate model, and group-ignorant model through extensive simulations. Finally, we demonstrated the utility of the JFM method in the motivating example to obtain fair risk predictions for under-represented older patients diagnosed with coronavirus disease 2019 (COVID-19).
In this paper, we address a variant of the marketing mix optimization (MMO) problem which is commonly encountered in many industries, e.g., retail and consumer packaged goods (CPG) industries. This problem requires the spend for each marketing activity, if adjusted, be changed by a non-negligible degree (minimum change) and also the total number of activities with spend change be limited (maximum number of changes). With these two additional practical requirements, the original resource allocation problem is formulated as a mixed integer nonlinear program (MINLP). Given the size of a realistic problem in the industrial setting, the state-of-the-art integer programming solvers may not be able to solve the problem to optimality in a straightforward way within a reasonable amount of time. Hence, we propose a systematic reformulation to ease the computational burden. Computational tests show significant improvements in the solution process.